Menu

Exclusive

Exclusive

HRSA Contacts 340B Providers Over Pharmacy Agreements Requested by Sanofi

William Newton, Editor-in-Chief 340B Report Views
Sanofi
Sanofi is seeking access to certain 340B pharmacy agreements services held by HRSA as part of ongoing litigation.
HRSA has contacted certain 340B providers about agreements with their contract pharmacies that could be released to French drugmaker Sanofi [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

Federal Judge Hearing PhRMA’s Maine 340B Law Challenge Was Partner at Firm that Lobbied for PhRMA Last Year Against Bill

William Newton, Editor-in-Chief 340B Report Views
U.S. Judge Joshua Dunlap
U.S. Judge Joshua Dunlap is one of three 1st Circuit judges hearing drug industry challenges to Maine’s 340B contract pharmacy access law.
A federal appellate judge hearing oral arguments today in PhRMA’s lawsuit challenging Maine’s 340B contract pharmacy access law was a [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

Q+A: Kalderos CEO Talks Truzo, 340B Rebate Model 

Shannon Young, Managing Editor 340B Report Views
Photo of Angie Franks
Kalderos CEO Angie Franks recently sat down with 340B Report to discuss how the company is approaching a range of 340B-related issues.
The head of Kalderos—which played a key role in the initial push for 340B rebates—recently offered 340B Report an exclusive [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

GOP Lawmaker Reverses Course on Earlier Support for 340B Rebates

William Newton, Editor-in-Chief 340B Report Views
U.S. Rep. Mike Ezell (R-Miss.) wrote a May 8 letter warning a 340B rebate could have "disastrous effects," shortly after he signed a letter earlier this month urging the Trump administration to adopt a 340B rebate model.
Just eight days after signing a U.S. House Republican letter supporting a “robust 340B rebate model pilot,” a Mississippi congressman [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

Novo Nordisk Says it Won’t Require Tennessee Providers to Report Claims Data Following AG Warning 

Luke Zarzecki, National Correspondent 340B Report Views
Novo Nordisk recently told a Tennessee official that it will not require state providers to submit 340B claims data after the state Attorney General's Office warned that the drugmaker’s new reporting requirements violated Tennessee law.
A major drugmaker recently told a Tennessee official that it will not require state providers to submit 340B claims data [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

Bergman, Ruiz to Introduce Bipartisan Bill Exempting Additional Covered Entities From 340B Rebates

Luke Zarzecki, National Correspondent 340B Report Views
US capitol dome exterior with US flag
U.S. Reps. Jack Bergman (R-Mich.) and Raul Ruiz (D-Calif.) are expected to soon introduce legislation to exempt certain covered entities from a 340B rebate model.
An expected bipartisan-backed U.S. House bill would exempt a range of covered entities, but not major hospitals, from 340B rebates—building [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

More than 1,100 Identical Comments Flood HRSA’s 340B Rebate RFI, All Linked to Pharma-Funded Patient Group

William Newton, Editor-in-Chief 340B Report Views
screenshot of highlighted 340B Rebate RFI
More than 80% of published comments on HRSA’s 340B rebate RFI so far are duplicates closely mirroring language from a Patients Rising templates.

The Health Resources and Services Administration (HRSA) has now received more than 1,100 identical public comments supporting 340B rebates tied to a template circulated by Patients Rising, a patient advocacy group that receives pharmaceutical industry funding.

The duplicate

…
Read More »

Exclusive

Most Early 340B Rebate Comments Are Duplicates Linked to Pharma-Funded Patient Group

William Newton, Editor-in-Chief 340B Report Views
A side-by-side of a Patients Rising template and an RFI comment.
More than half of early comments on HRSA’s 340B rebate RFI were identical submissions closely mirroring language from a Patients Rising template.
HRSA has published the first batch of stakeholder comments on its latest 340B rebate request for information (RFI)—and more than [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

SUSTAIN Act’s Introduction Stalled Amid Talks on 340B Rebates, Hot-Button Issues

Luke Zarzecki, National Correspondent 340B Report Views
Senators Jerry Moran (R-Kan.), Shelley Moore Capito (R-W.V.), Markwayne Mullin (R-Okla.), Tammy Baldwin (D-Wis.), John Hickenlooper (D-Colo.) and Tim Kaine (D-Va.)
Sen. Tim Kaine (D-Va.) told 340B Report there is seemingly a consensus against a 340B rebate model among senators in the 340B working group.
Members of a bipartisan U.S. Senate 340B working group signaled that their long-awaited bill remains a work in progress amid [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

House Lawmakers in Talks to Launch Bipartisan 340B Working Group as Counterpart to Senate ‘Gang of Six’

William Newton, Editor-in-Chief 340B Report Views
Some U.S. House members are said to be in early discussions to form a bipartisan 340B working group.
Several U.S. House lawmakers are in early talks to form a bipartisan 340B working group as a counterpart to the [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live